OnCo

PRDM2 (PR domain zinc finger protein 2) is a protein that switches other genes on and off. The public catalogues list it as an oncogene driver and a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Hepatocellular carcinoma, Renal cell carcinoma, Neuroblastoma and 1 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

S-adenosyl-L-methionine-dependent histone methyltransferase that specifically methylates 'Lys-9' of histone H3. May function as a DNA-binding transcription factor. Binds to the macrophage-specific TPA-responsive element (MTE) of the HMOX1 (heme oxygenase 1) gene and may act as a transcriptional activator of this gene. Location: Nucleus (UniProt). Locus 1p36.21 (HGNC).

Where it is found
  • Hepatocellular carcinoma: IntOGen driver in 1 cohort (HCC)
  • Renal cell carcinoma: IntOGen driver in 1 cohort (PRCC)
  • Neuroblastoma: IntOGen driver in 1 cohort (NBL)
  • Papillary renal cell carcinoma: IntOGen driver in 1 cohort (PRCC)
Class: transcription · Gene: PRDM2 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"PRDM2" OR ABSTRACT:"PRDM2" OR TITLE:"PR/SET domain 2" OR ABSTRACT:"PR/SET domain 2" OR TITLE:"PR domain zinc finger protein 2" OR ABSTRACT:"PR domain zinc finger protein 2" OR TITLE:"RIZ1" OR ABSTRACT:"RIZ1" OR TITLE:"RIZ2" OR ABSTRACT:"RIZ2" OR TITLE:"KMT8" OR ABSTRACT:"KMT8") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PRDM2, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/prdm2.json. Licence CC BY-NC 4.0.